Terms ending in 2040
Every in-force patent on Institut Pasteur de Lille's record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,403,188 | Bordetella Strains Expressing Serotype 3 Fimbriae In force · Medium confidence | Institut National de la Santé et de la Recherche Médicale (INSERM) | In force | Medium confidence | |
| US 11,975,072 | Pyropheophorbide Conjugate and Use Thereof in the Treatment of Cancer and as a Fluorescent Marker Inserm (Institut National de la Sante et de la Recherche Medicale, Universite de Lille, Centre National de la Recherche Scientifique, Universite de Lorraine, Institut Pasteur de Lille and Centre Hospitalier Regional Universitaire de Lille In force · High confidence | Inserm (Institut National de la Sante et de la Recherche Medicale, Universite de Lille, Centre National de la Recherche Scientifique, Universite de Lorraine, Institut Pasteur de Lille and Centre Hospitalier Regional Universitaire de Lille | In force | High confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.